- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Sectors
Treadwell Therapeutics steps to series B round
Sino Biopharmaceutical co-led the oncology treatment developer's latest round, in which it raised over $91m in funding.
Nov 23, 2021Ultraleap captures $81m in series D funding
IP Group returned for the Bristol spinout's series D that will go to product development and commercialisation.
Nov 23, 2021Deliverr captures $250m in series E round
GLP helped the e-commerce logistics provider raise series E funding that will support the expansion of its commercial operations and next-day fulfilment service.
Nov 23, 2021NoBroker nets $210m in series E funding
The Digital Garage-backed property listings platform developer’s latest round boosted its total funding to $361m and helped it achieve unicorn status.
Nov 23, 2021Schwarz sets up $700m XM Cyber acquisition
UST Global and Nasdaq are exiting the cybersecurity software developer in an acquisition by Aldi owner Schwartz Group.
Nov 23, 2021Vigil Neuroscience files for IPO
The neurodegenerative disease therapy developer has set a $100m placeholder target for an offering following $140m in funding from investors including Amgen and Pivotal BioVentures.
Nov 23, 2021Workday to buy Vndly for $510m
ServiceNow and Okta Ventures are set to exit the human resources software provider, which has raised at least $57.5m in funding.
Nov 23, 2021Pace accelerates with $40m
Marubeni Ventures and UOB Venture Management both contributed to a series A round for the online buy now, play later service.
Nov 23, 2021Housenbold falls for Leaf Home
The house renovator has hired GCV Rising Star Jeffrey Housenbold, formerly a founding managing partner at SBIA where he helped oversee the SoftBank Vision Funds.
Nov 23, 2021Miaki makes space for SM² accelerator
The joint initiative formed by digital product provider Miaki, SOSV and SBK will target Bangladesh-based seed-stage tech startups, having already chosen three candidates for a maiden cohort.
Nov 23, 2021Experian executes $320m Gabi acquisition
The purchase of the online insurance comparison service marked an off-ramp for corporate investors Securian, Northwestern Mutual and Cuna Mutual.
Nov 23, 2021Chroma colours in $125m series A
Bringing together researchers from Italy and the US, Chroma Medicine has emerged out of stealth with series A financing led by Cormorant Asset Management.
Nov 23, 2021Featured Content
The CVC Funding Round DatabaseRealtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.The CVC Funding Round Database
Realtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.
CVC DirectoryFull details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.CVC Directory
Full details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


